BHCM
TNDM icon

Brevan Howard Capital Management’s Tandem Diabetes Care TNDM Stock Holding History

Brevan Howard Capital Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$735K Buy
38,336
+4,245
+12% +$92.2K 0.01% 1078
2025
Q4 		$749K Sell
34,091
-92,797
-73% -$1.67M 0.01% 901
2025
Q3 		$1.54M Buy
126,888
+32,154
+34% +$435K 0.02% 688
2025
Q2 		$1.77M Buy
94,734
+83,955
+779% +$1.66M 0.02% 795
2025
Q1 		$207K Sell
10,779
-42,062
-80% -$1.23M 0.01% 973
2024
Q4 		$1.9M Buy
52,841
+30,909
+141% +$1.05M 0.05% 294
2024
Q3 		$930K Buy
+21,932
New +$930K 0.04% 477
2024
Q2 		– Sell
-12,087
Closed -$428K – 1413
2024
Q1 		$428K Buy
+12,087
New +$324K 0.04% 508

Other funds holding TNDM

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.26B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return